Supplemental Data
收藏Mendeley Data2024-01-31 更新2024-06-26 收录
下载链接：
https://data.mendeley.com/datasets/6h4gtrzgdc
下载链接
链接失效反馈官方服务：
资源简介：
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
创建时间：
2024-01-31
